for AVT05, Alvotech’s proposed biosimilar to Sim GlobeNewswire • 3 days ago Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major ...
The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...
STOCKHOLM, Jan. 31, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee for Medicinal Products ...
After hours: February 3 at 4:01:47 PM EST Loading Chart for ALVO ...
Poscierre: January 31 at 4:01:57 p.m. EST ...
After hours: January 31 at 7:58:37 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback